RJA
DH icon

Raymond James & Associates’s Definitive Healthcare DH Stock Holding History

Raymond James & Associates’s Portfolio DH Stock Details DH Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q3 		– Sell
-486,819
Closed -$2.66M – 4021
2024
Q2 		$2.66M Sell
486,819
-357,995
-42% -$2.25M ﹤0.01% 1984
2024
Q1 		$6.82M Buy
844,814
+248,266
+42% +$2.2M ﹤0.01% 1371
2023
Q4 		$5.93M Sell
596,548
-53,779
-8% -$422K ﹤0.01% 1422
2023
Q3 		$5.2M Buy
650,327
+126,613
+24% +$1.27M ﹤0.01% 1439
2023
Q2 		$5.76M Buy
523,714
+14,156
+3% +$146K ﹤0.01% 1387
2023
Q1 		$5.26M Buy
509,558
+341,464
+203% +$4.02M ﹤0.01% 1425
2022
Q4 		$1.85M Sell
168,094
-30,397
-15% -$391K ﹤0.01% 2036
2022
Q3 		$3.08M Buy
198,491
+5,577
+3% +$123K ﹤0.01% 1702
2022
Q2 		$4.42M Buy
192,914
+10,715
+6% +$229K ﹤0.01% 1475
2022
Q1 		$4.49M Buy
182,199
+88,420
+94% +$2M ﹤0.01% 1583
2021
Q4 		$2.56M Buy
+93,779
New +$3.28M ﹤0.01% 1995

Other funds holding DH

AI
Advent International Boston, Massachusetts $4.24B AUM 4.24% 1-Year Est. Return
ICM
Irenic Capital Management New York $1.54B AUM 12.79% 1-Year Est. Return
Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PCM
Palisade Capital Management Fort Lee, New Jersey $3B AUM 14% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Raymond James & Associates's DH Position: Q3 2024 in Review

Raymond James & Associates sold out of Definitive Healthcare (DH) in Q3 2024, closing a stake of 486,819 shares — an estimated $2.66M sold.

Raymond James & Associates first reported a position in DH in Q4 2021 and held it in 11 quarters. The position peaked at $6.82M in Q1 2024. 125 funds tracked by Wall St. Rank hold DH as of Q3 2024.

  • Raymond James & Associates reported no remaining Definitive Healthcare position as of Q3 2024 after selling out during the quarter.
  • Raymond James & Associates sold 486,819 Definitive Healthcare shares in Q3 2024, an estimated $2.66M.
  • Raymond James & Associates first reported a position in Definitive Healthcare in Q4 2021 and held it in 11 quarters.
  • Raymond James & Associates's Definitive Healthcare position peaked at $6.82M in Q1 2024.
  • 125 funds tracked by Wall St. Rank held Definitive Healthcare as of Q3 2024.

Based on Raymond James & Associates's 13F filing for Q3 2024, filed 18 Oct 2024.